222 related articles for article (PubMed ID: 18245271)
1. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
Liu L; Yang P; He H; Lin X; Jiang L; Chi W; Zhao C; Zhou H
Br J Ophthalmol; 2008 Apr; 92(4):557-61. PubMed ID: 18245271
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982
[TBL] [Abstract][Full Text] [Related]
3. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
4. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
Chi W; Yang P; Li B; Wu C; Jin H; Zhu X; Chen L; Zhou H; Huang X; Kijlstra A
J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients.
Yang K; Wen J; Liu X; Kijlstra A; Chen L; Chi W; Zhou H; Huang X; Yang P
Br J Ophthalmol; 2009 Feb; 93(2):249-53. PubMed ID: 19019941
[TBL] [Abstract][Full Text] [Related]
6. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
Yang Y; Xiao X; Li F; Du L; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):1012-7. PubMed ID: 22247488
[TBL] [Abstract][Full Text] [Related]
7. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease.
Li B; Yang P; Zhou H; Huang X; Jin H; Chu L; Gao Y; Zhu L; Kijlstra A
Br J Ophthalmol; 2005 Nov; 89(11):1410-2. PubMed ID: 16234441
[TBL] [Abstract][Full Text] [Related]
9. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
Li F; Yang P; Liu X; Wang C; Hou S; Kijlstra A
Arch Ophthalmol; 2010 Nov; 128(11):1449-54. PubMed ID: 21060047
[TBL] [Abstract][Full Text] [Related]
11. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.
Yi X; Yang P; Sun M; Yang Y; Li F
Mol Vis; 2011 Mar; 17():673-9. PubMed ID: 21403851
[TBL] [Abstract][Full Text] [Related]
12. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
Liu YX; Wang H; Peng XY; Zhou ZC
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.
Xu M; Wang C; Tian Y; Kijlstra A; Yang P
Ocul Immunol Inflamm; 2014 Aug; 22(4):294-9. PubMed ID: 24329541
[TBL] [Abstract][Full Text] [Related]
14. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
Peng Z; Jiang S; Wu M; Zhou X; Wang Q
Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease.
Jiang S; Liu X; Luo L; Qu B; Huang X; Xu L; Lin Y; Ye S; Liu Y
Br J Ophthalmol; 2010 Aug; 94(8):1078-82. PubMed ID: 19910285
[TBL] [Abstract][Full Text] [Related]
16. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
17. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
Sun M; Yang P; Du L; Yang Y; Ye J
PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905
[TBL] [Abstract][Full Text] [Related]
18. [The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].
Xiao T; Jiang Y; You X
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):268-71. PubMed ID: 10451958
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome.
Liu X; Yang P; Lin X; Ren X; Zhou H; Huang X; Chi W; Kijlstra A; Chen L
Clin Immunol; 2009 May; 131(2):333-42. PubMed ID: 19200788
[TBL] [Abstract][Full Text] [Related]
20. Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.
Otani S; Sakurai T; Yamamoto K; Fujita T; Matsuzaki Y; Goto Y; Ando Y; Suzuki S; Usui M; Takeuchi M; Kawakami Y
Br J Ophthalmol; 2006 Jun; 90(6):773-7. PubMed ID: 16481377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
